会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明专利
    • PREPARATION OF ALDEHYDE DEHYDROGENASE BOUND TO MEMBRANE
    • JPS58152480A
    • 1983-09-10
    • JP3518582
    • 1982-03-08
    • NAKANO SUTEN KK
    • TAYAMA KENJIFUKAYA MASAHIROFUJIYAMA SEIICHIMASAI HIROSHI
    • C12N9/04
    • PURPOSE:To prepare an aldehyde dehydrogenase bound to a membrane in high yield, by inoculating a strain belonging to acetic acid bacteria into a nutrient culture medium containing ethanol, and cultivating the strain. CONSTITUTION:A strain, e.g. Acetobacter MK-17 strain (FERM-P No.5747), belonging to acetic acid bacteria is inoculated into an ordinary culture medium for the acetic acid bacteria containing a carbon source, e.g. glucose, a nitrogen source, e.g. peptone, a salt, e.g. K, Ca or Mg, and a minor element, e.g. vitamin or amino acid, and cultivated therein. In a period before the completion of the logarithmic growth phase of the acetic acid bacteria, 0.1-4V/V% ethanol is added to the culture medium, and aerobically cultivated at 2.0-7.0pH and 25- 38 deg.C for 20-480hr. The resultant microbial cell is then collected and suspended in a buffer solution, destroyed and centrifuged at a low speed to remove the settling undestroyed microbial cell. The resultant supernatant liquid is then centrifuged at a high speed. A surfactant is then added to the precipitated membranous fraction to solubilize the enzyme, which is then purified by the chromatography to give the aimed aldehyde dehydrogenase bound to the membrane.
    • 17. 发明专利
    • PREPARATION OF ALCOHOLIC DEHYDROGENASE BOUND TO MEMBRANE
    • JPS58152479A
    • 1983-09-10
    • JP3518482
    • 1982-03-08
    • NAKANO SUTEN KK
    • FUJIYAMA SEIICHITAYAMA KENJIFUKAYA MASAHIROMASAI HIROSHI
    • C12N9/04
    • PURPOSE:To prepare an alcoholic dehydrogenase bound to a membrane, by ionculating a strain belonging to acetic acid bacteria into a nutrient culture medium containing ethanol, and cultivating the acetic acid bacteria. CONSTITUTION:A strain, e.g. Acetobacter MK-06 (FERM-P No.6173), belonging to acetic acid bacteria, and capable of producing an alcoholic dehydrogenase bound to a membrane is inoculated into an ordinary culture medium for the acetic acid bacteria containing a carbon source, e.g. glucose, a nitrogen source, e.g. peptone, a salt, e.g. K, Ca or Mg, and a minor element, e.g. vitamin or amino acid, and cultivated therein. In a period before the completion of the logarithmic growth phase of the acetic acid bacteria, 0.1-4V/V% ethanol is added to the culture medium and aerobically cultivated at 2.0-7.0pH and 25- 38 deg.C for 20-480hr. The microbial cell is then collected, suspended in a buffer solution, destroyed and centrifuged at a low speed to remove the undestroyed microbial cell. The resultant supernatant liquid is then centrifuged at a high speed, and a surfactant is added to the centrifuged membranous fraction to solubilize the enzyme, which is then purified by the chromatography to give the aimed alcoholic dehydrogenase bound to the membrane.
    • 18. 发明专利
    • ANTITUMOR SUBSTANCE
    • JPS57144221A
    • 1982-09-06
    • JP2940481
    • 1981-03-03
    • NAKANO SUTEN KK
    • FUJIYAMA SEIICHIFUKAYA MASAHIROHATA MORIMASAMIZUKAMI HIROYUKIYAMADA KOUKI
    • A61K35/74A61P35/00
    • PURPOSE:An antitumor substance that contains the cell wall fraction of cell bodies of a strain in Gluconobacter as an active ingredient. CONSTITUTION:A strain of a bacterium in Gluconobacter such as Gluconobacter oxydans IFO-3287 is aerobically cultured at 20-45 deg.C and its cell bodies are collected by centrifugation. These cell bodies are washed with a physiological salt solution to remove components in the culture medium and products formed outside cells to collects its cell bodies, which are crushed by means of, e.g., Dyno-Mill KDL. Then, the crushed product is subjected to low-speed contrifugation to remove uncrushed cell bodies as a precipitate and the upper layer solution is subjected to high-speed contrifugation. After the insoluble substance is separated, it is dispersed in distilled water, placed in a dialysis tube to effect dialysis in 20-50 times volume of distilled water one overnight. Then, the inner dialyzate is freeze dried into a powder to give the cell wall fraction of cell bodies. The objective antitumor agent is prepared by using the product as an active ingredient. Its does to, e.g., a mouse is intraperitoneally 1-200mg/kg and hypodemically 0.5-100mg/kg.